These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11124344)
1. Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Diamandis EP; Yousef GM; Soosaipillai AR; Bunting P Clin Biochem; 2000 Oct; 33(7):579-83. PubMed ID: 11124344 [TBL] [Abstract][Full Text] [Related]
2. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Diamandis EP; Yousef GM; Soosaipillai AR; Grass L; Porter A; Little S; Sotiropoulou G Clin Biochem; 2000 Jul; 33(5):369-75. PubMed ID: 11018688 [TBL] [Abstract][Full Text] [Related]
3. Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. Diamandis EP; Scorilas A; Fracchioli S; Van Gramberen M; De Bruijn H; Henrik A; Soosaipillai A; Grass L; Yousef GM; Stenman UH; Massobrio M; Van Der Zee AG; Vergote I; Katsaros D J Clin Oncol; 2003 Mar; 21(6):1035-43. PubMed ID: 12637468 [TBL] [Abstract][Full Text] [Related]
4. Human kallikrein 10: a novel tumor marker for ovarian carcinoma? Luo LY; Bunting P; Scorilas A; Diamandis EP Clin Chim Acta; 2001 Apr; 306(1-2):111-8. PubMed ID: 11282101 [TBL] [Abstract][Full Text] [Related]
5. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer. Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230 [TBL] [Abstract][Full Text] [Related]
6. Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. Hoffman BR; Katsaros D; Scorilas A; Diamandis P; Fracchioli S; Rigault de la Longrais IA; Colgan T; Puopolo M; Giardina G; Massobrio M; Diamandis EP Br J Cancer; 2002 Sep; 87(7):763-71. PubMed ID: 12232761 [TBL] [Abstract][Full Text] [Related]
7. Human kallikrein 6 as a biomarker of alzheimer's disease. Diamandis EP; Yousef GM; Petraki C; Soosaipillai AR Clin Biochem; 2000 Nov; 33(8):663-7. PubMed ID: 11166014 [TBL] [Abstract][Full Text] [Related]
8. Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation. Bayés A; Tsetsenis T; Ventura S; Vendrell J; Aviles FX; Sotiropoulou G Biol Chem; 2004 Jun; 385(6):517-24. PubMed ID: 15255184 [TBL] [Abstract][Full Text] [Related]
9. Characterisation of human kallikrein 6/protease M expression in ovarian cancer. Ni X; Zhang W; Huang KC; Wang Y; Ng SK; Mok SC; Berkowitz RS; Ng SW Br J Cancer; 2004 Aug; 91(4):725-31. PubMed ID: 15305183 [TBL] [Abstract][Full Text] [Related]
10. Potential markers that complement expression of CA125 in epithelial ovarian cancer. Rosen DG; Wang L; Atkinson JN; Yu Y; Lu KH; Diamandis EP; Hellstrom I; Mok SC; Liu J; Bast RC Gynecol Oncol; 2005 Nov; 99(2):267-77. PubMed ID: 16061277 [TBL] [Abstract][Full Text] [Related]
11. Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. Bandiera E; Zanotti L; Fabricio AS; Bucca E; Squarcina E; Romani C; Tassi R; Bignotti E; Todeschini P; Tognon G; Romagnolo C; Gion M; Sartori E; Maggino T; Pecorelli S; Ravaggi A Clin Chem Lab Med; 2013 Sep; 51(9):1815-24. PubMed ID: 24013103 [TBL] [Abstract][Full Text] [Related]
12. Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients. Luo LY; Soosaipillai A; Grass L; Diamandis EP Tumour Biol; 2006; 27(5):227-34. PubMed ID: 16864975 [TBL] [Abstract][Full Text] [Related]
13. The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry. Petraki CD; Karavana VN; Skoufogiannis PT; Little SP; Howarth DJ; Yousef GM; Diamandis EP J Histochem Cytochem; 2001 Nov; 49(11):1431-41. PubMed ID: 11668196 [TBL] [Abstract][Full Text] [Related]
14. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222 [TBL] [Abstract][Full Text] [Related]
15. Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancer. Liu X; Xiong H; Li J; He Y; Yuan X Diagn Pathol; 2013 Apr; 8():62. PubMed ID: 23587030 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors. Magklara A; Mellati AA; Wasney GA; Little SP; Sotiropoulou G; Becker GW; Diamandis EP Biochem Biophys Res Commun; 2003 Aug; 307(4):948-55. PubMed ID: 12878203 [TBL] [Abstract][Full Text] [Related]
17. Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin. Hutchinson S; Luo LY; Yousef GM; Soosaipillai A; Diamandis EP Clin Chem; 2003 May; 49(5):746-51. PubMed ID: 12709365 [TBL] [Abstract][Full Text] [Related]
18. [Correlation of hK6 expression with clinicopathological features and prognosis in epithelial ovarian cancer]. Hu CJ; Zhang F; Chen YJ; Sun XM; Zheng JF Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):520-3. PubMed ID: 19950700 [TBL] [Abstract][Full Text] [Related]
19. Study of kallikrein-related peptidase 6 (KLK6) and its complex with α1-antitrypsin in biological fluids. Korbakis D; Soosaipillai A; Diamandis EP Clin Chem Lab Med; 2017 Aug; 55(9):1385-1396. PubMed ID: 28672746 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of serum kallikrein-related peptidases 6 and 10 versus CA125 in ovarian cancer. El Sherbini MA; Sallam MM; Shaban EA; El-Shalakany AH Int J Gynecol Cancer; 2011 May; 21(4):625-32. PubMed ID: 21412167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]